Erratum: HSV amplicon-mediated Aβ vaccination in Tg2576 mice: Differential antigen-specific immune responses (Neurobiology of Aging (2005) 26 (393-407) DOI: 10.1016/j.neurobiolaging.2004.04.006);HSV amplicon-mediated Aβ vaccination in Tg2576 mice: Differential antigen-specific immune responses

Neurobiology of Aging

Volumn 26, Issue 4, 2005, Pages 393-407

  Bowers, William J ^a   Mastrangelo, Michael A ^a   Stanley, Hilary A ^a   Casey, Ann E ^a   Milo Jr , Lawrence J ^a   Federoff, Howard J ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Alzheimer's disease; Chemokine; Cytokine; Gene transfer; HSV amplicon vector; Inflammation; galactosidase

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; HERPES SIMPLEX VACCINE; HERPES SIMPLEX VIRUS VACCINE 1AC; TETANUS TOXIN; UNCLASSIFIED DRUG;

AMPLICON; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; HAMSTER; HERPES SIMPLEX VIRUS; HIPPOCAMPUS; HUMORAL IMMUNITY; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VACCINATION;

EID: 11844265865     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2004.12.001     Document Type: Erratum

References (65)

1. Akira S., Taga T., Kishimoto T. Interleukin-6 in biology and medicine. Adv. Immunol. 54:1993;1-78
2. Bacskai B.J., Kajdasz S.T., McLellan M.E., Games D., Seubert P., Schenk D., et al. Non-Fc-mediated mechanisms are involved in clearance of amyloid-beta in vivo by immunotherapy. J. Neurosci. 22(18):2002;7873-7878
3. Banchereau J., Bazan F., Blanchard D., Briere F., Galizzi J.P., van Kooten C., et al. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:1994;881-922
4. Bard F., Barbour R., Cannon C., Carretto R., Fox M., Games D., et al. Epitope and isotype specificities of antibodies to beta-amyloid peptide for protection against Alzheimer's disease-like neuropathology. Proc. Natl. Acad. Sci.: USA. 100(4):2003;2023-2028
5. Bard F., Cannon C., Barbour R., Burke R.L., Games D., Grajeda H., et al. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 6(8):2000;916-919
6. Becher B., Prat A., Antel J.P. Brain-immune connection: immuno-regulatory properties of CNS-resident cells. GLIA. 29(4):2000;293-304
7. Bernasconi N.L., Traggiai E., Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science. 298(5601):2002;2199-2202
8. Boehm U., Klamp T., Groot M., Howard J.C. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15:1997;749-795
9. Bowers WJ, Howard DF, Brooks AI, Halterman MW, Federoff HJ. Expression of vhs and VP16 during HSV-1 helper virus-free amplicon packaging enhances titers. Gene Ther 2001;8:111-20.
10. Bowers W.J., Howard D.F., Federoff H.J. Discordance between expression and genome transfer titering of HSV amplicon vectors: recommendation for standardized enumeration. Mol. Ther. 1(3):2000;294-299
11. Colton C.A., Yao J., Keri J.E., Gilbert D. Regulation of microglial function by interferons. J. Neuroimmunol. 40(1):1992;89-98
12. Das S., Potter H. Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1. Neuron. 14(2):1995;447-456
13. DeMattos R.B., Bales K.R., Cummins D.J., Dodart J.C., Paul S.M., Holtzman D.M. Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci.: USA. 98(15):2001;8850-8855
14. Di Santo E., Alonzi T., Fattori E., Poli V., Ciliberto G., Sironi M., et al. Overexpression of interleukin-6 in the central nervous system of transgenic mice increases central but not systemic proinflammatory cytokine production. Brain Res. 740(1/2):1996;239-244
15. Farrar M.A., Schreiber R.D. The molecular cell biology of interferon-gamma and its receptor. Annu. Rev. Immunol. 11:1993;571-611
16. Frei K., Siepl C., Groscurth P., Bodmer S., Schwerdel C., Fontana A. Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur. J. Immunol. 17(9):1987;1271-1278
17. Frey A., Di Canzio J., Zurakowski D. A statistically defined endpoint titer determination method for immunoassays. J. Immunol. Methods. 221(1/2):1998;35-41
18. Furlan R., Brambilla E., Sanvito F., Roccatagliata L., Olivieri S., Bergami A., et al. Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice. Brain. 126(Part 2):2003;285-291
19. Gadient R.A., Otten U.H. Interleukin-6 (IL-6) - a molecule with both beneficial and destructive potentials. Prog. Neurobiol. 52(5):1997;379-390
20. Geller A.I., Breakefield X.O. A defective HSV-1 vector expresses Escherichia coli β-galactosidase in cultured peripheral neurons. Science. 241:1988;1667-1669
21. Giovannini M.G., Scali C., Prosperi C., Bellucci A., Vannucchi M.G., Rosi S., et al. Beta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: involvement of the p38MAPK pathway. Neurobiol. Dis. 11(2):2002;257-274
22. Hardy J., Duff K., Hardy K.G., Perez-Tur J., Hutton M. Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau. Nat. Neurosci. 1(5):1998;355-358
23. Hauss-Wegrzyniak B., Lynch M.A., Vraniak P.D., Wenk G.L. Chronic brain inflammation results in cell loss in the entorhinal cortex and impaired LTP in perforant path-granule cell synapses. Exp. Neurol. 176(2):2002;336-341
24. Hewett S.J., Corbett J.A., McDaniel M.L., Choi D.W. Interferon-gamma and interleukin-1 beta induce nitric oxide formation from primary mouse astrocytes. Neurosci. Lett. 164(12):1993;229-232
25. Hickey W.F., Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science. 239(4837):1988;290-292
26. Hock C., Konietzko U., Papassotiropoulos A., Wollmer A., Streffer J., von Rotz R.C., et al. Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease. Nat. Med. 8(11):2002;1270-1275
27. Hock C., Konietzko U., Streffer J.R., Tracy J., Signorell A., Muller-Tillmanns B., et al. Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease. Neuron. 38(4):2003;547-554
28. Hocknell P.K., Wiley R.D., Wang X., Evans T.G., Bowers W.J., Hanke T., et al. Expression of human immunodeficiency virus type 1 gp120 from herpes simplex virus type 1-derived amplicons results in potent, specific, and durable cellular and humoral immune responses. J. Virol. 76(11):2002;5565-5580
29. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 274(5284):1996;99-102
30. Janus C. Vaccines for Alzheimer's disease: how close are we? CNS Drugs. 17(7):2003;457-474
31. Janus C., Pearson J., McLaurin J., Mathews P.M., Jiang Y., Schmidt S.D., et al. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature. 408(6815):2000;979-982
32. Lambert M.P., Barlow A.K., Chromy B.A., Edwards C., Freed R., Liosatos M., et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci.: USA. 95(11):1998;6448-6453
33. Lavi E., Suzumura A., Murasko D.M., Murray E.M., Silberberg D.H., Weiss S.R. Tumor necrosis factor induces expression of MHC class I antigens on mouse astrocytes. J. Neuroimmunol. 18(3):1988;245-253
34. Lu B., Federoff H.J. Herpes simplex virus type 1 amplicon vectors with glucocorticoid-inducible gene expression. Hum. Gene Ther. 6:1995;421-430
35. Lu C.H., Lee C.J., Kind P. Immune responses of young mice to pneumococcal type 9V polysaccharide-tetanus toxoid conjugate. Infect. Immun. 62(7):1994;2754-2760
36. Manz R.A., Thiel A., Radbruch A. Lifetime of plasma cells in the bone marrow. Nature. 388(6638):1997;133-134
37. Mathews P.M., Nixon R.A. Setback for an Alzheimer's disease vaccine: lessons learned. Neurology. 61(1):2003;7-8
38. Miller G.W., Nussenzweig V. A new complement function: solubilization of antigen-antibody aggregates. Proc. Natl. Acad. Sci.: USA. 72(2):1975;418-422
39. Miravalle L., Tokuda T., Chiarle R., Giaccone G., Bugiani O., Tagliavini F., et al. Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. J. Biol. Chem. 275(35):2000;27110-27116
40. Monsonego A., Maron R., Zota V., Selkoe D.J., Weiner H.L. Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease. Proc. Natl. Acad. Sci.: USA. 98(18):2001;10273-10278
41. Morgan D., Diamond D.M., Gottschall P.E., Ugen K.E., Dickey C., Hardy J., et al. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature. 408(6815):2000;982-985
42. Nicoll J.A., Wilkinson D., Holmes C., Steart P., Markham H., Weller R.O. Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat. Med. 9(4):2003;448-452
43. Nilsson L.N., Das S., Potter H. Effect of cytokines, dexamethasone and the A/T-signal peptide polymorphism on the expression of alpha(1)- antichymotrypsin in astrocytes: significance for Alzheimer's disease. Neurochem. Int. 39(5/6):2001;361-370
44. Olschowka J.A., Bowers W.J., Hurley S.D., Mastrangelo M.A., Federoff H.J. Helper-free HSV-1 amplicons elicit a markedly less robust innate immune response in the CNS. Mol. Ther. 7(2):2003;218-227
45. Orgogozo J.M., Gilman S., Dartigues J.F., Laurent B., Puel M., Kirby L.C., et al. Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology. 61(1):2003;46-54
46. Perry V.H., Bell M.D., Brown H.C., Matyszak M.K. Inflammation in the nervous system. Curr. Opin. Neurobiol. 5(5):1995;636-661
47. Petrushina I., Tran M., Sadzikava N., Ghochikyan A., Vasilevko V., Agadjanyan M.G., et al. Importance of IgG2c isotype in the immune response to beta-amyloid in amyloid precursor protein/transgenic mice. Neurosci. Lett. 338(1):2003;5-8
48. Robinson S.R., Bishop G.M., Munch G. Alzheimer vaccine: amyloid-beta on trial. Bioessays. 25(3):2003;283-288
49. Salio M., Cella M., Suter M., Lanzavecchia A. Inhibition of dendritic cell maturation by herpes simplex virus. Eur. J. Immunol. 29(10):1999;3245-3253
50. Schenk D., Barbour R., Dunn W., Gordon G., Grajeda H., Guido T., et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 400(6740):1999;173-177
51. Slifka M.K., Antia R., Whitmire J.K., Ahmed R. Humoral immunity due to long-lived plasma cells. Immunity. 8(3):1998;363-372
52. Spellerberg M.B., Zhu D., Thompsett A., King C.A., Hamblin T.J., Stevenson F.K. DNA vaccines against lymphoma: promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to tetanus toxin fragment C. J. Immunol. 159(4):1997;1885-1892
53. Taga T., Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15:1997;797-819
54. Thomas J., Rouse B.T. Immunopathogenesis of herpetic ocular disease. Immunol. Res. 16(4):1997;375-386
55. Town T., Vendrame M., Patel A., Poetter D., DelleDonne A., Mori T., et al. Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer's beta-amyloid (1-42). J. Neuroimmunol. 132(1/2):2002;49-59
56. Wade-Martins R., Frampton J., James M.R. Long-term stability of large insert genomic DNA episomal shuttle vectors in human cells. Nucleic Acids Res. 27(7):1999;1674-1682
57. Wade-Martins R., Saeki Y., Antonio Chiocca E. Infectious delivery of a 135-kb LDLR genomic locus leads to regulated complementation of low-density lipoprotein receptor deficiency in human cells. Mol. Ther. 7(5):2003;604-612
58. Wade-Martins R., Smith E.R., Tyminski E., Chiocca E.A., Saeki Y. An infectious transfer and expression system for genomic DNA loci in human and mouse cells. Nat. Biotechnol. 19(11):2001;1067-1070
59. Wang X., Wiley R.D., Evans T.G., Bowers W.J., Federoff H.J., Dewhurst S. Cellular immune responses to helper-free HSV-1 amplicon particles encoding HIV-1 gp120 are enhanced by DNA priming. Vaccine. 21(19/20):2003;2288-2297
60. Wang Y., Mukherjee S., Fraefel C., Breakefield X.O., Allen P.D. Herpes simplex virus type 1 amplicon vector-mediated gene transfer to muscle. Hum. Gene Ther. 13(2):2002;261-273
61. Weiner H.L., Selkoe D.J. Inflammation and therapeutic vaccination in CNS diseases. Nature. 420(6917):2002;879-884
62. White R.E., Wade-Martins R., James M.R. Infectious delivery of 120-kilobase genomic DNA by an epstein-barr virus amplicon vector. Mol. Ther. 5(4):2002;427-435
63. Williamson R., Scales T., Clark B.R., Gibb G., Reynolds C.H., Kellie S., et al. Rapid tyrosine phosphorylation of neuronal proteins including tau and focal adhesion kinase in response to amyloid-beta peptide exposure: involvement of Src family protein kinases. J. Neurosci. 22(1):2002;10-20
64. Willis R.A., Bowers W.J., Turner M.J., Fisher T.L., Abdul-Alim C.S., Howard D.F., et al. Dendritic cells transduced with HSV-1 amplicons expressing prostate-specific antigen generate antitumor immunity in mice. Hum. Gene Ther. 12(15):2001;1867-1879
65. Wyss-Coray T., Yan F., Lin A.H., Lambris J.D., Alexander J.J., Quigg R.J., et al. Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice. Proc. Natl. Acad. Sci.: USA. 99(16):2002;10837-10842